Author

Xiaolu Sun

Institution: Shenyang Pharmaceutical University

Observed institutions: Shenyang Pharmaceutical University, Shanghai Jiao Tong University, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Hospital

ORCID: 0000-0003-1768-2602

Observed ORCID: 0000-0003-1768-2602

OpenAlex ID: A5008624968

Targeted Therapy and Immunotherapy for Heterogeneous Breast Cancer

2022 · Xiaolu Sun, Kuai Liu, et al. · Cancers · 39

Precision Therapy of Recurrent Breast Cancer through Targeting Different Malignant Tumor Cells with a HER2/CD44‐Targeted Hydrogel Nanobot

2023 · Juan Chen, Jinjin Li, et al. · Small · 24

A pH-responsive cetuximab-conjugated DMAKO-20 nano-delivery system for overcoming K-ras mutations and drug resistance in colorectal carcinoma

2024 · Huiling Song, Haosheng Li, et al. · Acta Biomaterialia · 10

Utilizing a modified-Postoperative Morbidity Survey for assessing morbidity after laparoscopic or robot-assisted radical prostatectomy: a retrospective observational study

2024 · Wenping Peng, Xiaolu Sun, et al. · BMC Anesthesiology · 1

A novel nebulized 1,8-Cineole nanoemulsion for respiratory tract drug delivery to treat airway mucus hypersecretion

2025 · Shengqian Jiang, Dongqin Quan, et al. · Journal of Drug Delivery Science and Technology

Correction: Utilizing a modified-postoperative morbidity survey for assessing morbidity after laparoscopic or robot-assisted radical prostatectomy: a retrospective observational study

2024 · Wenping Peng, Xiaolu Sun, et al. · BMC Anesthesiology

A Bio-Responsive Cetuximab-Conjugated Dmako-20 Nano-Delivery System for Overcoming The K-Ras Mutations And Drug Resistance In Colorectal Carcinoma

2023 · Huiling Song, Haosheng Li, et al. · SSRN Electronic Journal

Works count: 7

Citation count: 74

H-index: 3

I10-index: 3